Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 775 of 1631 entries
View as:

BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01045902 Org: User:
Start: 02/28/01 End: 01/31/05 Due: 01/31/06

Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02822274 Org: User:
Start: 11/19/15 End: 12/02/15 Due: 12/02/16

Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01234337 Org: User:
Start: 02/21/11 End: 10/20/17 Due: 10/20/18

AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

Phase: N/A Priority: Normal
NCT ID: NCT00846911 Org: User:
Start: 04/30/08 End: 04/30/10 Due: 04/30/11

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03284762 Org: User:
Start: 09/11/17 End: 11/20/19 Due: 11/20/20

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00717561 Org: User:
Start: 02/29/08 End: 06/30/09 Due: 06/30/10

Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period

Phase: N/A Priority: Normal
NCT ID: NCT01076595 Org: User:
Start: 05/31/10 End: 07/31/14 Due: 07/31/15

Sorafenib Drug Drug Interaction Study in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02332031 Org: User:
Start: 02/28/15 End: 09/30/15 Due: 09/30/16

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01618370 Org: User:
Start: 07/22/12 End: 02/28/16 Due: 02/28/17

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00561717 Org: User:
Start: 10/31/07 End: 02/29/08 Due: 02/28/09

End-stage Renal Disease (ESRD) Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03787368 Org: User:
Start: 01/31/19 End: 09/15/21 Due: 09/15/22

Birth Control Patch Study

Phase: N/A Priority: Normal
NCT ID: NCT00984789 Org: User:
Start: 05/31/09 End: 09/30/10 Due: 09/30/11

BAY43-9006 Phase II Study for Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00661375 Org: User:
Start: 11/30/04 End: 03/31/06 Due: 03/31/07

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02396862 Org: User:
Start: 12/09/15 End: 03/26/18 Due: 03/26/19

Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00668005 Org: User:
Start: 02/28/03 End: 09/30/03 Due: 09/30/04

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

Phase: N/A Priority: Normal
NCT ID: NCT02090543 Org: User:
Start: 01/31/14 End: 10/31/14 Due: 10/31/15

Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216)

Phase: N/A Priority: Normal
NCT ID: NCT00770432 Org: User:
Start: 11/30/07 End: 01/31/08 Due: 01/31/09

Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety

Phase: N/A Priority: Normal
NCT ID: NCT01908322 Org: User:
Start: 08/31/13 End: 09/30/15 Due: 09/30/16

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06278207 Org: User:
Start: 05/15/24 End: 10/31/25 Due: 10/31/26

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04267939 Org: User:
Start: 02/26/20 End: 12/01/23 Due: 12/01/24

HR-QoL and Sexuality in Mirena Inserted Contraception Users

Phase: N/A Priority: Normal
NCT ID: NCT00498784 Org: User:
Start: 11/30/05 End: 10/31/07 Due: 10/31/08

PK in Pts With HRPC & Skeletal Metastes

Phase: N/A Priority: Normal
NCT ID: NCT00667537 Org: User:
Start: 07/31/07 End: 12/31/08 Due: 12/31/09

A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease

Phase: N/A Priority: Normal
NCT ID: NCT00453349 Org: User:
Start: 01/31/07 End: 05/31/08 Due: 05/31/09

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Phase: N/A Priority: Normal
NCT ID: NCT03890731 Org: User:
Start: 04/02/19 End: 02/28/23 Due: 02/28/24

Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862

Phase: N/A Priority: Normal
NCT ID: NCT01473108 Org: User:
Start: 03/29/10 End: 05/17/11 Due: 05/17/12